Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
LAB · NASDAQ · Pharmaceutical Preparations
$0.631+0.0173 (+2.82%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Standard Biotools (LAB) · oqro.io/stocks/LAB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 5, 2026 · Filed Nov 5, 2026
Director purchased ~$47K of LAB shares in the open marketSourceFederal contract · Signed Sep 2, 2026 · Updated Sep 2, 2026
Department of Commerce awarded STANDARD BIOTOOLS INC.: $25K obligated to dateSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
ARK Investment Management no longer reported LAB for Q1 2026SourceFederal contract · Signed Feb 26, 2026 · Updated Feb 26, 2026
Department of the Interior awarded STANDARD BIOTOOLS INC.: $15K obligated to dateSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 11, 2026
ARK Investment Management disclosed an increased position in LAB for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
ARK Investment Management disclosed a reduced position in LAB for Q3 2025SourceInsider trade · Traded Sep 9, 2025 · Filed Sep 12, 2025
Director purchased ~$129K of LAB shares in the open marketSourceInsider trade · Traded Sep 3, 2025 · Filed Sep 5, 2025
Director purchased ~$316K of LAB shares in the open marketSourceInsider trade · Traded Sep 4, 2025 · Filed Sep 5, 2025
Director purchased ~$319K of LAB shares in the open marketSourceInsider trade · Traded Aug 22, 2025 · Filed Aug 27, 2025
Director purchased ~$253K of LAB shares in the open marketSourceInsider trade · Traded Aug 25, 2025 · Filed Aug 27, 2025
Director purchased ~$248K of LAB shares in the open marketSourceInsider trade · Traded Aug 26, 2025 · Filed Aug 27, 2025
Director purchased ~$158K of LAB shares in the open marketSourceInsider trade · Traded Aug 15, 2025 · Filed Aug 16, 2025
Director purchased ~$183K of LAB shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Jul 30, 2025
ARK Investment Management disclosed a reduced position in LAB for Q2 2025SourceInsider trade · Traded May 22, 2025 · Filed May 28, 2025
CEO sold ~$5.1K of LAB shares in the open marketSourceInsider trade · Traded May 23, 2025 · Filed May 28, 2025
CEO sold ~$5.2K of LAB shares in the open marketSourceInsider trade · Traded May 22, 2025 · Filed May 28, 2025
CFO sold ~$1.4K of LAB shares in the open marketSourceInsider trade · Traded May 23, 2025 · Filed May 28, 2025
CFO sold ~$1.3K of LAB shares in the open marketSourceInsider trade · Traded Feb 28, 2025 · Filed Mar 5, 2025
Director purchased ~$5.13M of LAB shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 4, 2025
ARK Investment Management disclosed a reduced position in LAB for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Oct 31, 2024
ARK Investment Management disclosed a reduced position in LAB for Q3 2024SourceInsider trade · Traded Aug 14, 2025 · Filed Aug 16, 2025
Director purchased ~$162K of LAB shares in the open marketSourceInsider trade · Traded Aug 13, 2025 · Filed Aug 16, 2025
Director purchased ~$98K of LAB shares in the open marketSourceInsider trade · Traded May 23, 2025 · Filed May 28, 2025
Officer sold ~$12K of LAB shares in the open marketSourceInsider trade · Traded May 21, 2025 · Filed May 23, 2025
CEO sold ~$4.9K of LAB shares in the open marketSourceInsider trade · Traded May 21, 2025 · Filed May 23, 2025
CFO sold ~$1.4K of LAB shares in the open marketSourceInsider trade · Traded May 21, 2025 · Filed May 23, 2025
Officer sold ~$13K of LAB shares in the open marketSourceInsider trade · Traded May 22, 2025 · Filed May 23, 2025
Officer sold ~$13K of LAB shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 7, 2025
ARK Investment Management disclosed an increased position in LAB for Q1 2025Source